0001567619-19-000660.txt : 20190107 0001567619-19-000660.hdr.sgml : 20190107 20190107120841 ACCESSION NUMBER: 0001567619-19-000660 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190101 FILED AS OF DATE: 20190107 DATE AS OF CHANGE: 20190107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Baldasare Bryan T CENTRAL INDEX KEY: 0001761920 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14902 FILM NUMBER: 19512769 MAIL ADDRESS: STREET 1: 3471 RIVER HILLS DRIVE CITY: CINCINNATI STATE: OH ZIP: 45244 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERIDIAN BIOSCIENCE INC CENTRAL INDEX KEY: 0000794172 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 310888197 STATE OF INCORPORATION: OH FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 3471 RIVER HILLS DR CITY: CINCINNATI STATE: OH ZIP: 45244 BUSINESS PHONE: 5132713700 MAIL ADDRESS: STREET 1: 3471 RIVER HILLS DRIVE CITY: CINCINNATI STATE: OH ZIP: 45244 FORMER COMPANY: FORMER CONFORMED NAME: MERIDIAN DIAGNOSTICS INC DATE OF NAME CHANGE: 19920703 3 1 doc1.xml FORM 3 X0206 3 2019-01-01 0 0000794172 MERIDIAN BIOSCIENCE INC VIVO 0001761920 Baldasare Bryan T 3471 RIVER HILLS DRIVE CINCINNATI OH 45244 0 1 0 0 Chief Accounting Officer Common Stock 30871 D Stock Option (Right to Buy) 19.71 2020-08-04 Common Stock 1500 D Stock Option (Right to Buy) 19.56 2026-03-24 Common Stock 15000 D These non-qualified options were awarded under the 2004 Equity Compensation Plan and are fully vested and exercisable. These non-qualified options were awarded under the 2012 Stock Incentive Plan and vest in four equal installments from the date of grant (i.e., vest 25% per year until fully vested on March 24, 2020) /s/ F. Mark Reuter as Attorney-in-Fact for Bryan T. Baldasare 2019-01-07